- Grayscale Says Bitcoin May Benefit Less Than Ethereum, Solana if CLARITY Act Passes
- Bitcoin Holds $78K After 24% August Rally: Is a September Correction Coming?
- Science Applications 2Q Adj EPS $3.01 >SAIC
- Science Applications 2Q EPS $2.38 >SAIC
- Attackers drain 15.5M WFLOW from More Markets in suspected $9.3M Flow exploit
- Ayman ‘AiMan’ Mufleh projects HBAR could reach $6.76 if it matches Ethereum’s market cap
- Macquarie Upgrades Chagee to Outperform From Neutral, $10.20 Price Target
- Agree Realty Insider Bought Shares Worth $1,474,599, According to a Recent SEC Filing
- -- Earnings Flash (URL.CN) NameSilo Technologies Corp. Reports Q2 Revenue C$18.8M
- Coast Copper to Issue Vendor 300,000 Shrs at Deemed Price of C$0.345/Shr
- President Capital Management Downgrades Centrus Energy to Neutral From Buy, $306 Price Target
- Cerrado Gold to Raise C$10 Million Via Strategic Private Placement With Eric Sprott
- --GUIDANCE:(SAIC) Science Applications International Expects Fiscal 2027 Revenue Range $7.2B - $7.3B, vs. FactSet Est of $7.19B
- Qnity Electronics Unveils Stackplane Platform for Advanced Packaging
- Update: Market Chatter: SK Hynix Denies Report of Intel Foundry Partnership for HBM4E
- Aon to Acquire USI Insurance Services for $17 Billion
- --Apollo to Sell Cooling Systems Maker Kelvion to SLB for $4.1 Billion in Cash, Assumption of Debt
- Market Chatter: Coupang's South Korea Troubles Add to Washington-Seoul Trade Tensions
- --Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating
- Russia Opens Legal Crypto Trading, but Retail Investors Face $3,800 Limit
- RedHill Biopharma: Apotex Will Receive RedHill's 70% Interest in Talicia, Following Apotex's Prior Acquisition of Cumberland Pharmaceuticals' U.S. Branded Business >RDHL
- --GUIDANCE:(SAIC) Science Applications International Expects Fiscal 2027 Adjusted EPS Range $10.65 - $10.75, vs. FactSet Est of $10.18
- --Earnings Flash (SAIC) Science Applications International Posts Fiscal Q2 Revenue $1.88B, vs. FactSet Est of $1.76B
- RBC Raises Price Target on Mastercard to $696 From $642, Keeps Outperform Rating
- Security Concerns on an Altcoin Network: Mainnet Block Production Halted
- Markets pivot to September Fed rate hike: Five things to know in Bitcoin this week
- Press Release: TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
- RBC Raises Price Target on Lightspeed Commerce to $13 From $10, Keeps Outperform Rating
- Eli Lilly to Bay Merida Biosciences For Up to $2.875 Billion
- RBC Raises Price Target on Global Payments to $106 From $102, Keeps Sector Perform Rating
- RBC Raises Price Target on Shift4 Payments to $67 From $63, Keeps Outperform Rating
- Zedge Appoint Morris Berger as Chief Executive Officer, Effective Oct 1 >ZDGE
- GameStop Expects Higher 2Q Profit, Despite Lower Sales -- Update
- Blossom Gold Starts Drilling at Kamma Claims in Nevada
- RBC Raises Price Target on Flywire to $25 From $20, Keeps Outperform Rating
- Ranger Energy Services to Acquire STEP's US Coiled Tubing Assets
- RBC Raises Price Target on Corpay to $438 From $423, Keeps Sector Perform Rating
- Royal Bank of Canada Notches Solid Quarter; Strength Seen Reflected in Valuation -- Market Talk
- --Needham Initiates Babcock & Wilcox Enterprises at Buy
- DeFi lending exploit drains $9.3M from More Markets, leaves reserves razor-thin
- SLB to Buy Acquire Kelvion From Majority Owner Apollo, Funds Advised by Triton >SLB APO
- Aon Strikes Roughly $17 Billion Deal for Insurance Brokerage USI -- Update
- Jazz Pharmaceuticals Phase 3 Trial Shows Survival Benefit for Ziihera in Gastroesophageal Cancer
- SLB to Buy Kelvon For About $3.4 Billion Cash >SLB APO
- Canadian Jobs Growth Expected to Slow in August but Outlook Remains for Gradual Improvement, RBC Says
- Ladenburg Thalmann Adjusts Price Target on Sempra to $98 From $102.50, Maintains Buy Rating
- Gilat Accepts Commitments From Israeli Investors to Participate in $100 Million Convertible Notes Offering
- India's Economy Posts Robust Growth Despite Mideast Energy Shock
- Guggenheim Adjusts Price Target on TJX Companies to $152 From $175, Keeps Buy Rating
- Bitcoin risks drop to $74,000 support after lower high, long-term outlook intact
- Ethereum price analysis: Nine-day ETF inflow streak holds ETH near $2,500
- Solana market liquidation wipes out $2.2M as SOL price stalls
- Revolut euro stablecoin rollout hits 75 million app users in first test
- PG&E Shares Fall on Bill Requiring Utilities to Pay More After Wildfires
- Eli Lilly to Pay Up to $2.875 Billion Cash for Merida Biosciences >LLY
- Third Point’s Core Scientific Stake Puts Bitcoin Miner-To-AI Trade In Focus
- August Becomes Crypto’s Best Month of 2026
- Major Canadian Economic Indicators Expected This Week
- High Tide to Open 3 New Canna Cabana Stores in Canada
- Solana needs to hold $100, break $110.15 for a move toward $150
- Gulf Countries Invest Billions of Dollars in Building an Alternative Channel to Reduce Reliance on the Hormuz Strait
- GBP/USD Price Forecast: Finds ground slightly below 20-day EMA
- Rate-Hike Odds Are Rising and the Tech Rally Looks Vulnerable -- Barrons.com
- --Aon to Buy USI Insurance Services From KKR for $17 Billion
- GameStop Expects Higher 2Q Profit, Despite Lower Sales
- Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; SELLAS Life Sciences to Advance, Tesla to Decline
- Loop Capital Adjusts Price Target on Dell Technologies to $600 From $550, Maintains Buy Rating
- DA Davidson Adjusts Price Target on Airbnb to $220 From $175, Maintains Buy Rating
- Robinhood Chain Hits Record $874.8 Million Volume — Are Meme Coins Back?
- BeOne Medicines Reports Positive Phase 3 Survival Data for Ziihera Regimens
- GameStop to Exchange and Cancel $1.4 Billion in Convertible Notes
- Ranger Energy Services: Consideration Includes $22.5M in Cash and $5M in Equity, Based on 30-Day Trailing VWAP as of Day Prior to Closing >RNGR
- Susquehanna Adjusts Price Target on IBM to $235 From $225, Keeps Neutral Rating
- Nomura Downgrades MINISO Group Holding to Neutral From Buy, Cuts Price Target to $11.70 From $18.90
- KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating
- --HC Wainwright Initiates Scribe Therapeutics at Buy With $60 Price Target
- Zacatecas Silver Closes Final Tranche of Private Placement of Units
- Why Is the Crypto Market Down Today?
- Why Is Seeker (SKR) Price Up Today?
- Bitcoin, Ethereum and XRP Price Prediction: Where Prices Could Move Next
- XRP Surges 28.5% in Best August Performance Since 2021 as Spot ETFs Log $153.5M Boom
- India FQL Crypto Scam Explained: Why Guaranteed Crypto Returns Remain a Major Red Flag
- Bitcoin and XRP Face Data-Heavy Week as Several US Economic Events Loom
- U.S. Political, Economic Calendar - Week Ahead
- --Keefe Bruyette & Woods Initiates River City Bank at Outperform With $58 Price Target
- IDEAYA Biosciences Plans Phase 3 Trial for Lung Cancer Therapy
- Press Release: GameStop Announces Second Quarter 2026 Preliminary Results
- Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy
- Market Chatter: US Government Plans to Take 35% Stake in North American Blue Energy Partners' Venezuelan Oil Venture
- Daiwa Securities Adjusts Price Target on Intuit to $400 From $500, Keeps Outperform Rating
- BMO Capital Adjusts PT on Mid-America Apartment Communities to $152 From $155, Keeps Outperform Rating
- Raymond James Adjusts PT on Deere & Company to $730 From $700, Keeps Outperform Rating
- U.S. Treasury Yields, Dollar Retreat -- Market Talk
- Morgan Stanley Adjusts Pt on Honeywell International to $250 From $245, Maintains Equalweight Rating
- Citigroup Downgrades MINISO Group to Neutral From Buy, Adjusts Pt to $11.30 From $18.10
- Evercore ISI Adjusts PT on Rockwell Automation to $485 From $480, Maintains In Line Rating
- Market View: Actual crude oil flow in the Strait of Hormuz is the core factor determining oil prices
- The main contract of Brent crude oil futures has just exceeded the $91.00 per barrel mark, now quoted at $91.01 per barrel, up 3.13% on the day.
- Brent crude oil rose by about $1 in the short term, reaching a high of $91.08 per barrel.
- Arrowhead Pharmaceuticals' Plozasiran Meets Endpoints in Studies of Patients With Severe Hypertriglyceridemia
